SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207) — Feb 1, 2021

Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207)
Date: Feb. 1, 2021 · CIK: 0000727207 · Accession: 0001104659-21-010350

AI Filing Summary & Sentiment

File numbers found in text: 333-252470

Date
February 1, 2021
Author
Not clearly detected
Form
CORRESP
Company
Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207)

Letter

Accelerate Diagnostics, Inc.

3950 South Country Club Road, Suite 470

Tucson, Arizona 85714

February 1, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Re: Accelerate Diagnostics, Inc.

Registration Statement on Form S-3

File No. 333-252470

Request for Acceleration of Effectiveness

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on Thursday, February 4, 2021, or as soon thereafter as practicable.

The Registrant hereby authorizes Daniel M. Mahoney and Joshua Schneiderman, of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration.

[SIGNATURE PAGE FOLLOWS]

Very truly yours,
ACCELERATE DIAGNOSTICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

Accelerate Diagnostics, Inc.

3950 South Country Club Road, Suite 470

Tucson, Arizona 85714

February 1, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Re:   Accelerate Diagnostics, Inc.

Registration Statement on Form S-3

File No. 333-252470

Request for Acceleration of Effectiveness

Ladies and Gentlemen:

Pursuant to Rule 461 of the General
Rules and Regulations under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Registrant”)
hereby requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission
at 4:00 p.m., Eastern Time, on Thursday, February 4, 2021, or as soon thereafter as practicable.

The Registrant hereby authorizes
Daniel M. Mahoney and Joshua Schneiderman, of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration.

[SIGNATURE PAGE FOLLOWS]

    Very truly yours,

    ACCELERATE DIAGNOSTICS, INC.

    By:
    /s/ Steve Reichling

    Name:
    Steve Reichling

    Title:
    Chief Financial Officer

[SIGNATURE PAGE TO REQUEST FOR ACCELERATION]